Parkicapone is used to treat Parkinson disease. It acts as a catecholamine methyltransferase inhibitor, which helps increase the effectiveness of levodopa and prolong its effect in the brain. This helps improve control of motor symptoms such as tremors, muscle stiffness, and slow movement.
Parkicapone in uae helps reduce fluctuations in response to treatment in Parkinson patients who experience a decline in the effect of levodopa before the next dose. It provides the patient with greater motor stability and reduces periods of immobility that interfere with daily activities.
Parkicapone is considered a complementary component of drug treatment for Parkinson disease and should be used under the supervision of a specialist physician, adhering to the prescribed dosage to avoid potential side effects and ensure optimal therapeutic benefits that contribute to improving the patient quality of life.